Medicines and Healthcare products Regulatory AgencyIn Vitro Diagnostic roadmapPage summary: Change made: Time updated: Implementation of medical devices future regimePage summary: Change made: Time updated: Medical devices: get regulatory advice from the MHRAPage summary: Change made: Time updated: MHRA welcomes Professor Jonathan Benger CBE as new CEO of NICEPage summary: Change made: Time updated: Medical devices: conformity assessment and the UKCA markPage summary: Change made: Time updated: Professor Bola Owolabi CBE: Creating the Climate for Health EquityPage summary: Change made: Time updated: Health Institution Exemption for general medical devicesPage summary: Change made: Time updated: Medical devices: legal requirements for specific medical productsPage summary: Change made: Time updated: MHRA updates guidance on the Health Institution Exemption to support safe use of medical devicesPage summary: Change made: Time updated: MHRA strategy blog seriesPage summary: Change made: Time updated: MHRA Performance DataPage summary: Change made: Time updated: Regulation of AI in HealthcarePage summary: Change made: Time updated: MHRA seeks input on AI regulation at ‘pivotal moment’ for healthcarePage summary: Change made: Time updated: MHRA Safety Roundup: December 2025Page summary: Change made: Time updated: If you have any questions about the medical content in this email, contact MHRA on info@mhra.gov.uk Medicines: get scientific advice from MHRAPage summary: Change made: Time updated: Medical devices: list of UK approved bodiesPage summary: Change made: Time updated: |
Operational Information Sharing
Page summary:
Guidance for Marketing Authorisation (MA) applicants on providing consent to share operational information during the MA application process.
Change made:
Last updated 2 January 2026 – Amended the Operational Information Sharing Guidance to reflect the addition of Department of Health Northern Ireland to the list of Health System Partners. JM
Time updated:
9:00am, 2 January 2026
MHRA approves zapomeran (Kostaive) mRNA COVID-19 vaccine
Page summary:
As with any medicine, the MHRA will keep the safety and effectiveness of zapomeran under close review.
Change made:
First published.
Time updated:
1:37pm, 2 January 2026